Evoke Pharma (EVOK) Tops Q2 EPS by 17c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.56), $0.17 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
• Cerebras Q1 EPS miss sends shares down 9% after-hours